Pinsent Masons celebrates innovation in the Biotech Sector at Bionow Awards

10 Dec 2013 | 01:30 pm | 1 min. read

International law firm Pinsent Masons has presented UK company Cyprotex with the 'Service Company of the Year' award at the Bionow Annual Awards 2013.

The awards, which took place on Thursday 28th November at The Mere Golf Resort & Spa in Cheshire, celebrates business and innovation within the biomedical and life science sectors across Northern England and showcases the world class offerings in the region.  It is was attended by over 300 executives from across the biomedical industry.

Samantha Livesey, Partner at Pinsent Masons specialising in intellectual property and commercial contracts within the biotech sector, was delighted to present the Service Company of the Year Award to Cyptrotex, whose ADME-Tox contract research services scored strongly against the judging criteria of impact of service on the problem addressed, quality and innovation of service and strong business model. 

Anthony Baxter PhD, chief executive of Cyprotex, said: "We are delighted to have won the prestigious BioNow Service Company of the Year award. Our dedicated team at our facilities in the UK and the US has made this possible and they have worked hard to achieve where we are today...We are looking forward to further growth and expansion during 2014."

Samantha Livesey said: "The BioNow Annual Awards are a great opportunity to celebrate the continued innovation and hard work of the companies operating in the biomedical field in the North.  It was fantastic to see so many growth-orientated companies from this sector sharing their expertise and networking, whether their main operation was scientific, clinical or business related."

The Service Company of the Year was a hugely competitive category with runners up Cobra Biologics and Perfectus Biomed also both making strong submissions. 

Key Contacts

Latest press releases

Show me all press releases

Pinsent Masons appoints employment partner in Dublin

Multinational law firm Pinsent Masons has enhanced its employment law capabilities with the appointment of Dublin-based Dierdre Lynch to boost the firm’s multinational employment capabilities.

Pinsent Masons announces new co-heads of Madrid, Inmaculada Castelló and Fernando Gutiérrez

Multinational law firm Pinsent Masons has appointed Inmaculada Castelló and Fernando Gutiérrez as co-heads of the Madrid office as of 1 September 2022.

Pinsent Masons advises UMS Consulting on its acquisition by Expleo

Multinational law firm Pinsent Masons has advised the shareholders of UMS Consulting GmbH & Co. KG on the sale of their shares to Expleo Group S.A.S.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises UMS Consulting on its acquisition by Expleo

Multinational law firm Pinsent Masons has advised the shareholders of UMS Consulting GmbH & Co. KG on the sale of their shares to Expleo Group S.A.S.

Pinsent Masons Advises Accord Healthcare in Exclusive Licence Agreement with Myovant Sciences to Commercialise ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe

Pinsent Masons represented Accord Healthcare Ltd in an exclusive license agreement with Myovant Sciences to commercialise relugolix, Myovant’s advanced hormone-sensitive prostate cancer treatment, under the trade name ORGOVYX® in the European Economic Area, United Kingdom, Switzerland and Turkey.

Pinsent Masons launches parallel trade monitoring platform for life sciences sector

Multinational law firm Pinsent Masons launches innovative online tool to help life sciences organisations grappling with parallel trade management.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts